NCT05653180 2023-04-03
IBI310 in Combination With Sintilimab in Patients With Advanced Biliary Tract Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2 Unknown
Clinical Trials
6 trialsNCT04843943 2021-04-14
Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCC
Fudan University
Phase 1/2 Unknown
NCT04840758 2021-04-12
Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer
The First Affiliated Hospital of Xiamen University
Phase 1/2 Unknown
NCT04781413 2021-03-04
Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer
Ruijin Hospital
Phase 1/2 Unknown
NCT04567069 2020-09-28
Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment
The Second Hospital of Shandong University
Phase 1/2 Unknown
NCT04202601 2019-12-19
Efficacy and Safety Evaluation of Sintilimab in Combination With IBI310 as Treatment in Patients With EBV-Positive Gastric Cancer
Peking University
Phase 1/2 Unknown